Rob Sahr on the Administration’s Aggressive Approach to Bayh-Dole Compliance
In an attempt to rein in rising drug prices, the Biden administration unveiled a proposed framework of factors that federal agencies should consider when choosing whether to exercise so-called “march-in rights.” March-in...more